U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel), a New CAR T Cell Therapy for Adults with Relapsed or Refractory Large B-cell Lymphoma View more
FDA: Permits Marketing of New Device Designed to Reduce Sleep Disturbance Related to Nightmares in Certain Adults View more
Pelvital Announces FDA Clearance of Flyte™, In-Home Pelvic Floor Muscle Treatment for Stress Urinary Incontinence View more